Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting
-- Oral presentation on the relationship between B-cell subsets and NMOSD attacks to be held on April 23 at 1:48 p.m. EDT -- ... | April 20, 2023